• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于配体的药物虚拟筛选的深度学习方法综述。

A review of deep learning methods for ligand based drug virtual screening.

作者信息

Wu Hongjie, Liu Junkai, Zhang Runhua, Lu Yaoyao, Cui Guozeng, Cui Zhiming, Ding Yijie

机构信息

School of Electronic and Information Engineering, Suzhou University of Science and Technology, Suzhou 215009, China.

Yangtze Delta Region Institute (Quzhou), University of Electronic Science and Technology of China, Quzhou 324000, China.

出版信息

Fundam Res. 2024 Mar 11;4(4):715-737. doi: 10.1016/j.fmre.2024.02.011. eCollection 2024 Jul.

DOI:10.1016/j.fmre.2024.02.011
PMID:39156568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11330120/
Abstract

Drug discovery is costly and time consuming, and modern drug discovery endeavors are progressively reliant on computational methodologies, aiming to mitigate temporal and financial expenditures associated with the process. In particular, the time required for vaccine and drug discovery is prolonged during emergency situations such as the coronavirus 2019 pandemic. Recently, the performance of deep learning methods in drug virtual screening has been particularly prominent. It has become a concern for researchers how to summarize the existing deep learning in drug virtual screening, select different models for different drug screening problems, exploit the advantages of deep learning models, and further improve the capability of deep learning in drug virtual screening. This review first introduces the basic concepts of drug virtual screening, common datasets, and data representation methods. Then, large numbers of common deep learning methods for drug virtual screening are compared and analyzed. In addition, a dataset of different sizes is constructed independently to evaluate the performance of each deep learning model for the difficult problem of large-scale ligand virtual screening. Finally, the existing challenges and future directions in the field of virtual screening are presented.

摘要

药物研发成本高昂且耗时,现代药物研发工作越来越依赖于计算方法,旨在减少与该过程相关的时间和资金支出。特别是在诸如2019年冠状病毒大流行等紧急情况下,疫苗和药物研发所需的时间会延长。最近,深度学习方法在药物虚拟筛选中的表现尤为突出。如何总结药物虚拟筛选中现有的深度学习方法,针对不同的药物筛选问题选择不同的模型,发挥深度学习模型的优势,并进一步提高深度学习在药物虚拟筛选中的能力,已成为研究人员关注的问题。本文综述首先介绍了药物虚拟筛选的基本概念、常用数据集和数据表示方法。然后,对大量用于药物虚拟筛选的常见深度学习方法进行了比较和分析。此外,还独立构建了不同规模的数据集,以评估每个深度学习模型在大规模配体虚拟筛选难题上的性能。最后,介绍了虚拟筛选领域目前存在的挑战和未来方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/38d626d99277/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/65a0e5959ab2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/67a291914c47/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/e103afd3a7d7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/f9c9f7946506/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/c22b2c8797e6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/38d626d99277/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/65a0e5959ab2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/67a291914c47/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/e103afd3a7d7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/f9c9f7946506/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/c22b2c8797e6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e8f/11330120/38d626d99277/gr6.jpg

相似文献

1
A review of deep learning methods for ligand based drug virtual screening.基于配体的药物虚拟筛选的深度学习方法综述。
Fundam Res. 2024 Mar 11;4(4):715-737. doi: 10.1016/j.fmre.2024.02.011. eCollection 2024 Jul.
2
Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases.深度学习和机器智能在计算机药物发现中的最新应用:方法、工具和数据库。
Brief Bioinform. 2019 Sep 27;20(5):1878-1912. doi: 10.1093/bib/bby061.
3
Deep Learning in Virtual Screening: Recent Applications and Developments.深度学习在虚拟筛选中的应用及进展。
Int J Mol Sci. 2021 Apr 23;22(9):4435. doi: 10.3390/ijms22094435.
4
When drug discovery meets web search: Learning to Rank for ligand-based virtual screening.当药物发现遇上网络搜索:基于配体的虚拟筛选的排序学习
J Cheminform. 2015 Feb 13;7:5. doi: 10.1186/s13321-015-0052-z. eCollection 2015.
5
Virtual Screening Meets Deep Learning.虚拟筛选与深度学习相遇
Curr Comput Aided Drug Des. 2019;15(1):6-28. doi: 10.2174/1573409914666181018141602.
6
Employing Molecular Conformations for Ligand-Based Virtual Screening with Equivariant Graph Neural Network and Deep Multiple Instance Learning.利用基于分子构象的等价图神经网络和深度多重实例学习进行配体虚拟筛选。
Molecules. 2023 Aug 9;28(16):5982. doi: 10.3390/molecules28165982.
7
DeepScreening: a deep learning-based screening web server for accelerating drug discovery.DeepScreening:一个基于深度学习的药物筛选网络服务器,用于加速药物发现。
Database (Oxford). 2019 Jan 1;2019. doi: 10.1093/database/baz104.
8
Comprehensive Survey of Recent Drug Discovery Using Deep Learning.深度学习在药物发现中的最新应用综述
Int J Mol Sci. 2021 Sep 15;22(18):9983. doi: 10.3390/ijms22189983.
9
Biomedical Data and Deep Learning Computational Models for Predicting Compound-Protein Relations.生物医学数据和深度学习计算模型用于预测化合物-蛋白质关系。
IEEE/ACM Trans Comput Biol Bioinform. 2022 Jul-Aug;19(4):2092-2110. doi: 10.1109/TCBB.2021.3069040. Epub 2022 Aug 8.
10
Artificial intelligence: Machine learning approach for screening large database and drug discovery.人工智能:用于筛选大型数据库和药物发现的机器学习方法。
Antiviral Res. 2023 Dec;220:105740. doi: 10.1016/j.antiviral.2023.105740. Epub 2023 Nov 5.

引用本文的文献

1
Advances and challenges in drug design against dental caries: Application of approaches.抗龋齿药物设计的进展与挑战:方法的应用
J Pharm Anal. 2025 Jun;15(6):101161. doi: 10.1016/j.jpha.2024.101161. Epub 2024 Dec 9.
2
Discovery of novel GluN1/GluN3A NMDA receptor inhibitors using a deep learning-based method.使用基于深度学习的方法发现新型GluN1/GluN3A N-甲基-D-天冬氨酸受体抑制剂。
Acta Pharmacol Sin. 2025 May 12. doi: 10.1038/s41401-025-01571-1.
3
Spectra-descriptor-based machine learning for predicting protein-ligand interactions.

本文引用的文献

1
Evolutionary-scale prediction of atomic-level protein structure with a language model.用语言模型进行原子级蛋白质结构的进化尺度预测。
Science. 2023 Mar 17;379(6637):1123-1130. doi: 10.1126/science.ade2574. Epub 2023 Mar 16.
2
Predicting drug-target binding affinity through molecule representation block based on multi-head attention and skip connection.基于多头注意力机制和跳跃连接的分子表示块预测药物-靶标结合亲和力。
Brief Bioinform. 2022 Nov 19;23(6). doi: 10.1093/bib/bbac468.
3
CoaDTI: multi-modal co-attention based framework for drug-target interaction annotation.
基于光谱描述符的机器学习用于预测蛋白质-配体相互作用。
Chem Sci. 2025 Mar 13;16(15):6355-6365. doi: 10.1039/d5sc00451a. eCollection 2025 Apr 9.
4
New strategies to enhance the efficiency and precision of drug discovery.提高药物研发效率和精准度的新策略。
Front Pharmacol. 2025 Feb 11;16:1550158. doi: 10.3389/fphar.2025.1550158. eCollection 2025.
5
The role of artificial intelligence in drug screening, drug design, and clinical trials.人工智能在药物筛选、药物设计和临床试验中的作用。
Front Pharmacol. 2024 Nov 29;15:1459954. doi: 10.3389/fphar.2024.1459954. eCollection 2024.
6
Natural volatiles preventing mosquito biting: An integrated screening platform for accelerated discovery of ORco antagonists.天然挥发性物质防止蚊虫叮咬:用于加速发现嗅觉受体共受体(ORco)拮抗剂的综合筛选平台。
J Biol Chem. 2024 Dec;300(12):107939. doi: 10.1016/j.jbc.2024.107939. Epub 2024 Oct 29.
7
Causal enhanced drug-target interaction prediction based on graph generation and multi-source information fusion.基于图生成和多源信息融合的因果增强药物-靶标相互作用预测。
Bioinformatics. 2024 Oct 1;40(10). doi: 10.1093/bioinformatics/btae570.
CoaDTI:基于多模态协同注意力的药物-靶标相互作用标注框架。
Brief Bioinform. 2022 Nov 19;23(6). doi: 10.1093/bib/bbac446.
4
Cross-modality and self-supervised protein embedding for compound-protein affinity and contact prediction.跨模态和自监督的蛋白质嵌入方法用于化合物-蛋白质亲和力和接触预测。
Bioinformatics. 2022 Sep 16;38(Suppl_2):ii68-ii74. doi: 10.1093/bioinformatics/btac470.
5
Ligand Binding Prediction Using Protein Structure Graphs and Residual Graph Attention Networks.基于蛋白质结构图和残差图注意力网络的配体结合预测。
Molecules. 2022 Aug 11;27(16):5114. doi: 10.3390/molecules27165114.
6
Boosting Protein-Ligand Binding Pose Prediction and Virtual Screening Based on Residue-Atom Distance Likelihood Potential and Graph Transformer.基于残基-原子距离似然势和图Transformer的蛋白质-配体结合构象预测和虚拟筛选的提升。
J Med Chem. 2022 Aug 11;65(15):10691-10706. doi: 10.1021/acs.jmedchem.2c00991. Epub 2022 Aug 2.
7
AttentionSiteDTI: an interpretable graph-based model for drug-target interaction prediction using NLP sentence-level relation classification.AttentionSiteDTI:一种基于图的可解释模型,用于使用 NLP 句子级关系分类进行药物-靶点相互作用预测。
Brief Bioinform. 2022 Jul 18;23(4). doi: 10.1093/bib/bbac272.
8
Effective drug-target interaction prediction with mutual interaction neural network.基于相互作用神经网络的有效药物-靶标相互作用预测。
Bioinformatics. 2022 Jul 11;38(14):3582-3589. doi: 10.1093/bioinformatics/btac377.
9
Drug-target affinity prediction using graph neural network and contact maps.使用图神经网络和接触图进行药物-靶点亲和力预测。
RSC Adv. 2020 Jun 1;10(35):20701-20712. doi: 10.1039/d0ra02297g. eCollection 2020 May 27.
10
Improved drug-target interaction prediction with intermolecular graph transformer.基于分子图转换器的药物-靶标相互作用预测方法的改进
Brief Bioinform. 2022 Sep 20;23(5). doi: 10.1093/bib/bbac162.